Georgetown, TX—Gilad&Gilad is relocating its offices to Georgetown, Texas, in an effort to invest in the development and marketing of its G-Agmatine-based products.

“We are relocating to Austin because of new business connections and proximity to good medical centers," said Dr. Gad M. Gilad, CEO of Gilad&Gilad. "The move will facilitate marketing of our signature products, AgmaSet and AgmaVet, which are superior for supporting proper nerve functions in humans and animals, respectively. The move will also enable clinical studies aimed at substantiating the effectiveness of novel G-Agmatine-based products in supporting additional bodily functions."

The company will maintain its contract manufacturing location in Southern California.
Related: FDA Warns Companies for Mental Health Claims Transparency: The clear choice for supplement consumers Testing Conducted by NOW Raises “Profound Concerns” About ALA on Amazon